Delaware is currently home to 303 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including Newark, Wilmington, Lewes and Rehoboth Beach. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
Recruiting
This study will evaluate the use of non- TBI (total body irradiation) conditioning for B-ALL patients with low risk of relapse as defined by absence of NGS-MRD (next generation sequencing minimal residual disease) before receiving a hematopoietic cell transplant (HCT). Patients diagnosed with B-ALL who are candidates for HCT will be screened by NGS-MRD on a test of bone marrow done before the HCT. Subjects who are pre-HCT NGS-MRD negative will be eligible to receive a non-TBI conditioning regime... Read More
Gender:
All
Ages:
Between 1 year and 25 years
Trial Updated:
08/20/2021
Locations: Alfred I. duPont Hospital for Children - Nemours Deleware, Wilmington, Delaware
Conditions: B-cell Acute Lymphoblastic Leukemia
Online Motor Control in People With Parkinson's Disease
Recruiting
This study aims to better understand how people with Parkinson's control reaching movements. Specifically, we are asking how these individuals respond to different environmental perturbations. Testing includes reaching movements made within a virtual reality set-up.
Gender:
All
Ages:
Between 18 years and 85 years
Trial Updated:
10/30/2020
Locations: University of Delaware, Newark, Delaware
Conditions: Motor Control, Parkinson Disease
University of Delaware Parkinson's Disease Registry
Recruiting
The purpose of this Parkinson's Disease Registry is to assist with recruitment of willing participants into future Parkinson's disease research studies at the University of Delaware.
Gender:
All
Ages:
Between 21 years and 100 years
Trial Updated:
10/26/2020
Locations: University of Delaware, Newark, Delaware
Conditions: Parkinson Disease